The COVID-19 vaccine hypothesis has been centered around induction of neutralizing antibodies (nAbs) that either block the interaction of the RBD with ACE2, or prevent the fusion process involving S protein transition from pre- to post-fusion conformation40,41. The gene discussed is ACE2; the disease is COVID-19.